The Iliac/SFA/Popliteal Center

Filter Your Results




Covered Stents for the Treatment of SFA Occlusive Disease

Subhash Banerjee, MD; Emmanouil S. Brilakis, MD, PhD; and Tony S. Das, MD

October 2008—A case-based discussion of stent graft use in this challenging anatomy.

Drug-Coated Balloons

Gunnar Tepe, MD, and Ulrich Speck, Phd

October 2008—Paclitaxel-coated balloons show promise as a treatment option for intravascular interventions.

Practical Uses of Cryoplasty

Pranab Das, MD; Santosh K. Koshy, MD; Robert S. Dieter, MD, RVT; and Aravinda Nanjundappa, MD, RVT

October 2008—A look at some of the effective applications of this nonsurgical treatment option.

Lessons Learned in RESILIENT

October 2008—Co-Principal Investigator John R. Laird Jr, MD, discusses the results and impact of this landmark SFA stenting trial.

Plaque Excision Treatment of Infrainguinal PAD

Roger Gammon, MD

June 2005—An update on this nonstenting alternative, with intermediate-term results of the ongoing TALON Registry.

Cryoplasty for Treating Femoropopliteal Occlusive Disease

Bret N. Wiechmann, MD, and Sandy E. Knight, RT(R)(CV), CCRC

June 2005—A single-center experience suggests that cryoplasty is effective first-line therapy and reduces target lesion revascularization.

Remote Endarterectomy Update

John D. Martin, MD

June 2005—An endovascular alternative to bypass?

Do the TASC Guidelines Still Apply?

Dierk Scheinert, MD

May 2005—Current available data suggest that an adjustment may be necessary.



US Device Guide

The Endovascular Today Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.